Home / Current Issue / Paper 1705975
The Rise of Antimicrobial Resistance: A Public Health Crisis
Subject area: Science,Engineering and Technology · Area of research: Public Health
Abstract
Antimicrobial resistance (AMR) is an escalating worldwide health issue that affects our capacity to successfully treat bacterial infections (Wright, 2020). The World Health Organisation (WHO) has recognised AMR as one of the foremost global health hazards facing humanity, carrying the potential for catastrophic repercussions (WHO, 2020). Antimicrobial resistance (AMR) arises when bacteria acquire traits or methods to circumvent the impact of antimicrobial medicines, including antibiotics, antivirals, and antifungals (CDC, 2020).
References
[1] Bergman, P., et al. (2023) ‘Fever prevents the development of antimicrobial resistance in bacteria’, Nature Medicine, 29(1), pp. 123-132.
[2] Cassini, A., et al. (2020) ‘Attributable deaths and disability-adjusted life-years due to antimicrobial resistance in the EU and EEA’, Eurosurveillance, 25(10), p. 1900434.
[3] Centers for Disease Control and Prevention. (2020). Antimicrobial resistance: Threats in the United States.
[4] Centers for Disease Control and Prevention. (2022). Antimicrobial resistance: Threats in the United States.
[5] Chen, Y., et al. (2022) ‘Machine learning for predicting antimicrobial resistance’, Nature Medicine, 28(1), pp. 113-122.
[6] Food and Drug Administration. (2022). Antimicrobial resistance.
[7] Department of Health and Human Services. (2022). Antimicrobial resistance.
[8] Laxminarayan, R., et al. (2020) ‘The global economic burden of antimicrobial resistance’, Journal of Global Health, 10(1), p. 010401.
[9] National Institutes of Health. (2022). Antimicrobial resistance.
[10] O'Neill, J. (2016) Tackling drug-resistant infections globally: Final report and recommendations. Review on Antimicrobial Resistance.
[11] Peto, T. E. A., et al. (2020) ‘The global burden of antimicrobial resistance’, The Lancet Infectious Diseases, 20(11), pp. 1373-1384.
[12] Robledo, I. E., et al. (2020) ‘Antimicrobial resistance: A global health crisis’, American Journal of Infection Control, 48(6), pp. 631-638.
[13] Tacconelli, E., et al. (2020) ‘Antimicrobial stewardship: A call to action for physicians and policymakers’, The Lancet Infectious Diseases, 20(11), p. 134.
[14] Wang, Y., et al. (2022) ‘Antimicrobial peptides: A promising approach to combating antimicrobial resistance’, Nature Reviews Drug Discovery, 21(2), pp. 123-136.
[15] World Health Organization. (2020). Antimicrobial resistance.
[16] World Health Organization. (2020). Global action plan on antimicrobial resistance.
[17] Wright, G. D. (2020) ‘The antibiotic resistance epidemic’, Nature, 586(7829), pp. 362-367.
How to cite this paper
@article{1705975,
author = {Omotosho Ajibola Adunola},
title = {The Rise of Antimicrobial Resistance: A Public Health Crisis},
journal = {Iconic Research And Engineering Journals},
year = {2024},
volume = {7},
number = {12},
pages = {419-421},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1705975.pdf},
abstract = {Antimicrobial resistance (AMR) is an escalating worldwide health issue that affects our capacity to successfully treat bacterial infections (Wright, 2020). The World Health Organisation (WHO) has recognised AMR as one of the foremost global health hazards facing humanity, carrying the potential for catastrophic repercussions (WHO, 2020). Antimicrobial resistance (AMR) arises when bacteria acquire traits or methods to circumvent the impact of antimicrobial medicines, including antibiotics, antivirals, and antifungals (CDC, 2020).},
month = {June},
}